424 related articles for article (PubMed ID: 14676081)
21. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
22. [The number and distribution of nevus cell nevi in patients with malignant melanoma].
Welkovich B; Landthaler M; Schmoeckel C; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517
[TBL] [Abstract][Full Text] [Related]
23. So-called "malignant blue nevus": a clinicopathologic study of 23 patients.
Martin RC; Murali R; Scolyer RA; Fitzgerald P; Colman MH; Thompson JF
Cancer; 2009 Jul; 115(13):2949-55. PubMed ID: 19472395
[TBL] [Abstract][Full Text] [Related]
24. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
Geller AC; Mayer JE; Sober AJ; Miller DR; Argenziano G; Johnson TM; Swetter SM
JAMA Dermatol; 2016 Apr; 152(4):413-8. PubMed ID: 26934430
[TBL] [Abstract][Full Text] [Related]
25. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
26. [Desmoplastic Spitz nevus: a histopathological review and comparison with desmoplastic melanoma].
Nojavan H; Cribier B; Mehregan DR
Ann Dermatol Venereol; 2009 Oct; 136(10):689-95. PubMed ID: 19801251
[TBL] [Abstract][Full Text] [Related]
27. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
28. Dermoscopic features of difficult melanoma.
Pizzichetta MA; Stanganelli I; Bono R; Soyer HP; Magi S; Canzonieri V; Lanzanova G; Annessi G; Massone C; Cerroni L; Talamini R;
Dermatol Surg; 2007 Jan; 33(1):91-9. PubMed ID: 17214687
[TBL] [Abstract][Full Text] [Related]
29. Grading of atypia in nevi: correlation with melanoma risk.
Arumi-Uria M; McNutt NS; Finnerty B
Mod Pathol; 2003 Aug; 16(8):764-71. PubMed ID: 12920220
[TBL] [Abstract][Full Text] [Related]
30. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.
Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti G; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Paoli S; Bottoni U; Lo Scocco G; Scalvenzi M; Giannotti B
Dermatol Surg; 2004 Nov; 30(11):1371-5; discussion 1375-6. PubMed ID: 15522016
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with a high tumour thickness in patients with melanoma.
Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
[TBL] [Abstract][Full Text] [Related]
32. Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes.
Shields CL; Furuta M; Mashayekhi A; Berman EL; Zahler JD; Hoberman DM; Dinh DH; Shields JA
Ophthalmology; 2008 Mar; 115(3):546-552.e2. PubMed ID: 18067966
[TBL] [Abstract][Full Text] [Related]
33. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.
Tan KB; Moncrieff M; Thompson JF; McCarthy SW; Shaw HM; Quinn MJ; Li LX; Crotty KA; Stretch JR; Scolyer RA
Am J Surg Pathol; 2007 Dec; 31(12):1902-12. PubMed ID: 18043047
[TBL] [Abstract][Full Text] [Related]
34. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
[TBL] [Abstract][Full Text] [Related]
35. Multiple primary melanoma: the impact of atypical naevi and follow up.
de Giorgi V; Rossari S; Papi F; Gori A; Alfaioli B; Grazzini M; Crocetti E; Verdelli A; Foo CW; Lotti T
Br J Dermatol; 2010 Dec; 163(6):1319-22. PubMed ID: 20670298
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
37. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
38. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
Boniol M; Armstrong BK; Doré JF
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.
Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Guillén C; Fortea JM
Acta Derm Venereol; 2006; 86(1):50-6. PubMed ID: 16585990
[TBL] [Abstract][Full Text] [Related]
40. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
